The latter, a chemoattractant for B lymphocytes, plays an important role in tertiary lymphoid structure formation, and is expressed in conjunction with exhaustion markers in tumour reactive CD8+ TILs [13]. The gene discussed is CD8A; the disease is neoplasm.